Skip to content. | Skip to navigation


Personal tools

Stuart Peacock

Distinguished Scientist

 

Stuart Peacock

Telephone: 604-675-8068
Fax: 604-675-8180
675 W 10th Ave., Vancouver, BC V5Z 1L3

 

Research Roles:

 

Education:

  • PhD (Economics), University of York, UK, 1998
  • MsC (Health Economics), University of York, UK, 1992
  • BA (Industrial Economics), The University of Leeds, UK, 1991

 

Research Interests:

  • Health Economics
  • Economics of Cancer and Cancer Genetics
  • Priority Setting Methods in Health
  • Program Budgeting and Marginal Analysis (PBMA)
  • Methods for Measuring Health-Related Quality of Life
  • Equity and the Value of Health
  • Health Econometrics


Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship and is a Professor in the Faculty of Health Sciences, Simon Fraser University. He is currently Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is a pan-Canadian research centre providing interdisciplinary leadership in health economics, services, policy and ethics research. Stuart is also a Distinguished Scientist in Cancer Control Research at the BC Cancer Agency, a member of the Board of Directors of the Canadian Agency for Drugs and Technologies in Health, and past President of the International Society on Priorities in Health Care. He has held university positions in Canada, Australia and the UK. Over the past 20 years, Stuart’s main research interests have focussed on research into developing more effective cancer services, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors. 

Current BC Cancer Agency projects are:

Principal Investigator

  • Priority Setting Methods in Cancer: Evidence-Based Marginal Analysis (2006-2009)
  • Long term income and employment among childhood, adolescent and young adult cancer survivors: data linkage platform, methods and analysis (2008-2013)
  • National Centre for Health Economics, Services, Policy and Ethics in Cancer (2009-2014)


Co-Investigator

  • Optical Techniques and Oral Pre-cancer Management (2005-2010)
  • Priority setting, health care utilisation and outcomes evaluation in seniors' care in Interior Health (2006-2009)
  • A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening (2006-2013)
  • Factors influencing the adoption of new cancer drugs across various institutional contexts (2007-2010)
  • Genomic, Imaging and Modelling Approaches to Advance Population-Based Colorectal Cancer Screening (2007-2012)
  • Rationing and moral distress in two health authorities in British Columbia (2008-2009)
  • Screening practices in women with and without a personal and family history of breast cancer: a population-based study (2008-2011)
  • The cost-effectiveness of cancer drugs funded by the New Drug Funding Program: Providing evidence of the value of medicines in delivering expected outcomes (2008-2011)
  • Early detection of lung cancer − a pan−Canadian study (2008-2013)
  • Childhood, adolescent and young adult cancer survivor research (2008-2013)
  • Phase-specific and lifetime costs of cancer in British Columbia and Ontario (2009-2013)


Past CHEC and CCR projects are:

  • Valuing health outcomes for policy decisions (2007-2008)
  • Rationing in health care: developing a BC based team and a provincial program of research (2007-2008)
  • A comparison of condition specific versus generic health state utilities in persons with Rheumatoid Arthritis (2007-2008)
  • Bevacizumab outcomes assessment: A pragmatic population-based study (2006-2008)
  • Public involvement in health care priority setting: a scoping review (2006-2007)
  • Cancer and Health Economics Research Program (2005-2007)